백화식물을 이용하여 천연 안토시아닌을 다량 함유하는 식물 조직을 생산하는 방법
    21.
    发明授权
    백화식물을 이용하여 천연 안토시아닌을 다량 함유하는 식물 조직을 생산하는 방법 失效
    使用白色植物生产含有大量天然花色素苷的植物组织的方法

    公开(公告)号:KR100292291B1

    公开(公告)日:2001-06-01

    申请号:KR1019980040566

    申请日:1998-09-29

    Abstract: 천연 안토시아닌은 식품은 물론 화장품의 색소첨가제로서 이용된 뿐만 아니라 의약품으로도 사용되어 그 수요가 증가되고 있다. 본 발명은 식물 카로티노이드 생성 억제제를 처리하여 얻은 백화 식물조직 절편을, 과당, 자당 및 포도당 중에서 선택된 어느 하나가 0.25중량%∼5중량%로 첨가된 용액 위에 띄우고, 광도가 6,000∼9,000 룩스이며, 배양온도가 28±4℃인 조건에서 2∼4일 동안 배양하여 안토시아닌을 축적시키는 것이 특징인 백화식물을 이용하여 천연 안토시아닌을 다량 함유하는 식물조직을 생산하는 방법에 관한다.
    본 방법은 무균 작업 과정이 필요 없고, 1회 생산을 위해 소요된 기간이 보통 10일 이내이면서 연중 생산이 가능하며, 생산에 필요한 경비(배양, 추출 등)가 적게 든다는 장점을 가지고 있다.

    삼백초와 황금의 혼합 추출물을 유효성분으로 함유하는골다공증 예방 또는 치료용 조성물
    23.
    发明公开
    삼백초와 황금의 혼합 추출물을 유효성분으로 함유하는골다공증 예방 또는 치료용 조성물 无效
    含有麻醉中药和麻黄碱混合物的混合物的组合物用于预防或治疗骨质疏松症

    公开(公告)号:KR1020100009151A

    公开(公告)日:2010-01-27

    申请号:KR1020080069892

    申请日:2008-07-18

    CPC classification number: A61K36/539 A61K36/78 A61K2300/00

    Abstract: PURPOSE: A composition containing mixture extract of Saururus chinensis and Scutellaria baicalensis is provided to suppress osteoclast differentiation, enhance bone density and bone content, and prevent or treat osteoporosis. CONSTITUTION: A pharmaceutical composition for preventing or treating osteoporosis contains mixture extract of Saururus chinensis and Scutellaria baicalensis as an active ingredient. The weight ratio of the Saururus chinensis and Scutellaria baicalensis is 1:10-10:1. A food composition for preventing and relieving osteoporosis contains mixture extract of Saururus chinensis and Scutellaria baicalensis as an active ingredient. A method for producing the mixture extract comprises: a step of washing Saururus chinensis and Scutellaria baicalensis with water and drying; a step of extracting the Saururus chinensis and Scutellaria baicalensis with solvent; a step of cooling the extract at room temperature and filtering; a step of decompress-concentrating and freeze-drying; and a step of mixing the extract of Saururus chinensis and Scutellaria baicalensis.

    Abstract translation: 目的:提供含有Saururus chinensis和黄芩的混合物提取物的组合物,以抑制破骨细胞分化,增强骨密度和骨含量,并预防或治疗骨质疏松症。 构成:用于预防或治疗骨质疏松症的药物组合物含有中华黄牛和黄芩的混合物提取物作为活性成分。 中华黄牛和黄芩的重量比为1:10-10:1。 用于预防和缓解骨质疏松症的食物组合物含有中华黄芪和黄芩的混合物提取物作为活性成分。 制备混合物提取物的方法包括:用水洗涤中华黄芩和黄芩的步骤; 用溶剂萃取中华黄龙和黄芩的一步; 在室温下冷却提取物并过滤的步骤; 减压浓缩和冷冻干燥步骤; 并将中国黄芪和黄芩提取物混合在一起。

    유백피 추출물을 포함하는 혈관 이완용 조성물
    24.
    发明公开
    유백피 추출물을 포함하는 혈관 이완용 조성물 有权
    包含ULMUS MACROCARPA提取物的挥发性效应的组合物

    公开(公告)号:KR1020090064823A

    公开(公告)日:2009-06-22

    申请号:KR1020070132164

    申请日:2007-12-17

    Abstract: A composition for relaxing blood vessel which contains an Ulmus macrocarpa extract prevent and treat various cardiovascular diseases by inducing the relaxation of vascular smooth muscle. A pharmaceutical composition for relaxing blood vessel contains an Ulmus macrocarpa extract as an active ingredient. The composition is effective in preventing and treating hypertension, coronary artery disease, cerebrovascular disease, peripheral vascular disease, main artery disease, kidney dysfunction, cardiac insufficiency or vision disorder An organic solvent for extracting the Ulmus macrocarpa is selected from ethanol, ethanol solution, methanol, methanol solution, butanol, dichloromethane, ethyl acetate, hexane and their mixture. A health food having the effect of blood vessel relaxation contains Ulmus macrocarpa extract.

    Abstract translation: 用于放松血管的组合物含有榆木提取物通过诱导血管平滑肌的松弛来预防和治疗各种心血管疾病。 用于放松血管的药物组合物含有榆木大pa提取物作为活性成分。 该组合物有效预防和治疗高血压,冠状动脉疾病,脑血管疾病,外周血管疾病,主动脉疾病,肾功能不全,心功能不全或视力障碍。用于提取榆树的有机溶剂选自乙醇,乙醇溶液,甲醇 ,甲醇溶液,丁醇,二氯甲烷,乙酸乙酯,己烷及其混合物。 具有血管松弛作用的保健食品包含榆树提取物。

    삼백초 뿌리 추출물 또는 이로부터 분리된 활성성분을포함하는 혈관 이완용 조성물
    26.
    发明公开
    삼백초 뿌리 추출물 또는 이로부터 분리된 활성성분을포함하는 혈관 이완용 조성물 有权
    包含SAURURUS CHINENESIS或其活性化合物的根提取物的挥发性影响的组合物

    公开(公告)号:KR1020080064238A

    公开(公告)日:2008-07-09

    申请号:KR1020070000902

    申请日:2007-01-04

    Abstract: A composition comprising a root extract of Saururus chinensis or a compound isolated from the extract is provided to show excellent blood pressure lowering effect through vascular relaxation, thereby being usefully used as a pharmaceutical composition or a health food composition for preventing and treating various cardiovascular diseases caused by hypertension and complications of the hypertension. A pharmaceutical composition for vascular relaxation comprises a compound selected from the group consisting of machilin D, saucerneol D and a mixture thereof or a root extract of Saururus chinensis comprising the same compound as an effective ingredient, wherein the extract is prepared by using an organic solvent selected from the group consisting of ethanol, an aqueous solution of the ethanol, methanol, an aqueous solution of the methanol, butanol. dichloromethane, ethylacetate, hexane and a mixture thereof.

    Abstract translation: 提供了包含中华鲟的根提取物或从提取物中分离的化合物的组合物,以通过血管松弛显示优异的降血压效果,从而有效地用作预防和治疗引起的各种心血管疾病的药物组合物或保健食品组合物 通过高血压和并发症的高血压。 用于血管松弛的药物组合物包含选自机体D,香草醇D及其混合物的化合物或包含与有效成分相同的化合物的中华黄瓜的根提取物,其中所述提取物通过使用有机溶剂 选自乙醇,乙醇水溶液,甲醇,甲醇水溶液,丁醇组成的组。 二氯甲烷,乙酸乙酯,己烷及其混合物。

    육두구 추출물 또는 이로부터 분리된 활성 화합물을포함하는 골다공증 예방 또는 치료용 조성물
    27.
    发明授权
    육두구 추출물 또는 이로부터 분리된 활성 화합물을포함하는 골다공증 예방 또는 치료용 조성물 失效
    用于预防或治疗包含神经胶质纤维素或其活性化合物的提取物的组合物的组合物

    公开(公告)号:KR100844376B1

    公开(公告)日:2008-07-07

    申请号:KR1020070012901

    申请日:2007-02-07

    Abstract: A composition comprising an extract of Myristica fragrans is provided to promote activity of osteoblast, thereby being usefully used to prevent or treat osteoporosis. A composition for preventing or treating osteoporosis comprises machilin A represented by a formula 1, macelignan represented by a formula 2, machilin F represented by a formula 3, nectandrin B represented by a formula 4, safrole represented by a formula 5, licarin A represented by a formula 6, licarin B represented by a formula 7, myristagenol A represented by a formula 8, meso-dihydroguaiaretic acid represented by a formula 9, a mixture thereof or an extract of Myristica fragrans comprising the compounds of the formulae(1) to (9) as effective ingredients, wherein the extract is prepared by using a solvent selected from the group consisting of C1-4 alcohol and an aqueous solution thereof, dichloromethane, ethyl acetate and a mixture thereof.

    Abstract translation: 提供包含肉豆蔻提取物的组合物以促进成骨细胞的活性,从而有用地用于预防或治疗骨质疏松症。 用于预防或治疗骨质疏松症的组合物包括由式1表示的机械A,由式2表示的肉豆蔻衣木脂素,由式3表示的机械纤维F,由式4表示的nectandrin B,由式5表示的黄樟素, 式6,由式7表示的赖氨酸B,由式8表示的肉豆蔻酰胺A,由式9表示的内消旋 - 二氢愈创木酸,其混合物或肉豆蔻提取物,其包含式(1)至( 9)作为有效成分,其中所述提取物通过使用选自C 1-4醇及其水溶液,二氯甲烷,乙酸乙酯及其混合物的溶剂制备。

    삼백초 추출물 또는 이로부터 분리된 활성 화합물을포함하는 골다공증 예방 또는 치료용 조성물
    28.
    发明授权
    삼백초 추출물 또는 이로부터 분리된 활성 화합물을포함하는 골다공증 예방 또는 치료용 조성물 有权
    用于预防或治疗包含SAURURUS CHINENSIS或活性化合物提取物的OSTEOPOSOSIS的组合物,其分离

    公开(公告)号:KR100833654B1

    公开(公告)日:2008-05-29

    申请号:KR1020070013661

    申请日:2007-02-09

    CPC classification number: A61K36/78

    Abstract: A composition comprising the extract of Saururus chinensis or active compounds isolated therefrom is provided to inhibit growth of osteoclast, so that the composition is useful for preventing or treating osteoporosis. A composition for preventing or treating osteoporosis comprises 0.01-30 wt.% of the extract of Saururus chinensis, which is prepared by extracting Saururus chinensis with C1-4 alcohol and its solution, dichloromethane, ethylacetate or a mixture thereof, or active compounds isolated from the Saururus chinensis extract including (-)-saucerneol represented by the formula(1) and sauristolactam represented by the formula(2), and is a pharmaceutical or health food composition having a formulation of beverage.

    Abstract translation: 提供了包含中华黄牛提取物或从其分离的活性化合物的组合物以抑制破骨细胞的生长,使得该组合物可用于预防或治疗骨质疏松症。 用于预防或治疗骨质疏松症的组合物包括通过用C 1-4醇提取中华黄芪和其溶液,二氯甲烷,乙酸乙酯或其混合物或从其中分离的活性化合物制备的中华黄瓜提取物的0.01-30重量% 含有由式(1)表示的( - ) - 三氯蔗糖和由式(2)表示的沙拉耳内酰胺,是具有饮料配方的药物或保健食品组合物。

    BACE-1의 활성을 저해하는 파고지 종자 추출물 또는이로부터 분리된 활성물질을 포함하는 퇴행성 뇌질환의예방 또는 치료용 조성물
    29.
    发明授权
    BACE-1의 활성을 저해하는 파고지 종자 추출물 또는이로부터 분리된 활성물질을 포함하는 퇴행성 뇌질환의예방 또는 치료용 조성물 有权
    用于预防或治疗包含来自一种PSORALEA CORYLIFOLIA的一种提取物的神经变性疾病的组合物抑制BACE-1或其活性成分的活性

    公开(公告)号:KR100833652B1

    公开(公告)日:2008-05-29

    申请号:KR1020060136696

    申请日:2006-12-28

    Abstract: A composition comprising the extract of Psoralea corylifolia seed or effective compounds contained therein is provided to inhibit the activity of BACE-1(beta-site APP(amyloid precursor protein)-cleaving enzyme 1) mediating the formation of beta-amyloid as a main causing material of dementia, so that the composition is useful for preventing or treating neurodegenerative disease. A composition for preventing or treating neurodegenerative disease comprises the extract of Psoralea corylifolia seed, which is prepared by extracting Psoralea corylifolia seeds with C1-4 alcohol or its solution, dichloromethane, ethylacetate or a mixture thereof, or a compound selected from 7-hydroxy-3-(4-methyl-4-(4-methylpentene-3-yl)-4H-chromen-6-yl)-4H-chromen-4-one represented by the formula(1), bakuchiol, bavachromene, isobavachromene, bavachalcone, isobavachalcone, bavachinin, 7,8-dihydro-8-(4-hydrophenyl)-2,2-dimethyl-2H,6H-[1,2-b:5,4-b']dipyran-6-one isolated from the extract of Psoralea corylifolia seed.

    Abstract translation: 提供包含补骨脂素提取物或其中含有的有效化合物的组合物以抑制BACE-1(β-位点APP(淀粉样蛋白前体蛋白)切割酶1)的活性,其介导β-淀粉样蛋白的形成作为主要原因 因此该组合物可用于预防或治疗神经退行性疾病。 用于预防或治疗神经退行性疾病的组合物包括通过用C 1-4醇或其溶液,二氯甲烷,乙酸乙酯或其混合物或选自7-羟基-2-甲基苯酚的化合物提取茄科植物提取物的方法制备的补骨脂素提取物, 由式(1)表示的3-(4-甲基-4-(4-甲基戊烯-3-基)-4H-色烯-6-基)-4H-色烯-4-酮,苯甲酸,巴伐溴苯,异葎草酮,巴伐昔酮 ,异哈查酮,巴伐他丁,7,8-二氢-8-(4-氢苯基)-2,2-二甲基-2H,6H- [1,2-b:5,4-b']二吡喃-6-酮 茯苓提取物。

    BACE-1 저해 효과를 갖는 포도나무 수피 추출물 또는이로부터 분리된 활성물질을 포함하는 퇴행성 뇌질환의예방 또는 치료용 조성물
    30.
    发明授权
    BACE-1 저해 효과를 갖는 포도나무 수피 추출물 또는이로부터 분리된 활성물질을 포함하는 퇴행성 뇌질환의예방 또는 치료용 조성물 有权
    用于预防或治疗包含来自具有对BACE-1或其活性成分的抑制作用的VITIS VINIFERA的提取物的提取物的神经损伤性疾病的组合物

    公开(公告)号:KR100791862B1

    公开(公告)日:2008-01-07

    申请号:KR1020060090116

    申请日:2006-09-18

    Abstract: A compound having a BACE-1 inhibitory effect and an extract obtained from bark of grapevine and containing the same compound are provided to obtain a pharmaceutical composition or health-aid food for preventing or treating neurodegenerative diseases. A compound having a BACE-1 inhibitory effect is represented by the following formula 1. The compound represented by formula 1 is obtained through an extraction process using an organic solvent selected from the group consisting of C1-C4 alcohols or aqueous solution thereof, dichloromethane, ethyl acetate and a mixture thereof. Particularly, the compound represented by formula 1 is obtained by extracting bark of grapevine with the organic solvent, and by further extracting the extract with an organic solvent selected from the group consisting of butanol, dichloromethane and ethyl acetate.

    Abstract translation: 提供具有BACE-1抑制作用的化合物和由葡萄树皮提取并含有相同化合物的提取物,以获得用于预防或治疗神经变性疾病的药物组合物或保健食品。 具有BACE-1抑制效果的化合物由下式1表示。式1所示的化合物是通过使用选自C1-C4醇或其水溶液,二氯甲烷, 乙酸乙酯及其混合物。 特别地,由式1表示的化合物是通过用有机溶剂提取葡萄树皮,并通过用选自丁醇,二氯甲烷和乙酸乙酯的有机溶剂进一步提取提取物而获得的。

Patent Agency Ranking